Chad Cowan, Chief Scientific Officer at Century Therapeutics, Inc. (IPSC), bought 58,060 shares at $0.85 ($49K) on 2025-12-22, disclosed to the SEC on 2025-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.